SCALE Healthcare Leadership Conference on October 18, 2023 at 8:00 AM-6:00 PM. Click here to register

Most Recently Approved Drugs Target Genetic Diseases and Cancer

The field of cellular and genetic therapies is rapidly progressing. Since the start of 2023, many novel medications have received FDA approval, including treatments for solid tumors and hematologic malignancies, as well as rare genetic disorders.
Share This Post

Log in

If you are a community member

Thanks for visiting!

Put your email and we promise we won’t spam you. We have so much to show you.

Join SCALE Community

We are excited for you to share in the benefits of SCALE community’s healthcare focus materials. If you are not currently a member sign up now to get unlimited access to all our materials.